Federal investment in research, education and awareness is critical to win the war on ovarian cancer.

For Policy Makers

This year alone, at least 21,000 women will be diagnosed with ovarian cancer, while 14,000 will die. While we continue to make progress in the war on other types of cancer, these rates have changed very little for ovarian cancer in the last 40 years.

These grim statistics arise from the fact that there is no early detection test for ovarian cancer. More than 80 percent of cases of ovarian cancer are diagnosed late, when the disease is most difficult to treat.

For Policymakers

We are in dire need of better awareness of the disease, new screening tests and better treatments for ovarian cancer. These are only possible with sustained federal investment in ovarian cancer research and education efforts:

Ovarian Cancer Research Program (OCRP): The OCRP, a Congressionally Directed Medical Research Program in the Department of Defense (DoD), funds innovative and cutting edge ovarian cancer research. Since 1997, the OCRP has been addressing unmet research needs by establishing funding priorities, crafting new grant mechanisms and supporting high-risk, high-reward research proposals. For more information, click here.

Johanna’s Law: Johanna’s Law funds the Inside Knowledge Campaign, a gynecological cancer awareness project run by the Centers for Disease Control and Prevention (CDC). This program educates women and health care professionals about the signs and symptoms of gynecologic cancers. For more information, click here.

Ovarian Cancer Control Initiative: Housed at CDC, this program supports a wide variety of projects that aim to enhance ovarian cancer survivorship and understanding of ovarian cancer risk. For more information, click here.

National Cancer Institute at the National Institutes of Health: The National Cancer Institute (NCI) and the National Institutes of Health (NIH) work to reduce cancer incidence and mortality through basic, translational and clinical biomedical research. NCI and NIH support ovarian cancer research through a competitive, peer-reviewed grant process. For more information, click here.

Click here for a brief overview of these programs:

The Alliance also supports policies that increase women’s access to preventative services and effective treatments for ovarian cancer. Click here for our policy positions or click here to see our archive of policy documents.